Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
---|
06/20/2013 | US20130158261 Protease inhibitors |
06/20/2013 | US20130158076 Methylene Urea Derivatives |
06/20/2013 | US20130158057 Aminopyrimidine derivatives as lrrk2 modulators |
06/20/2013 | US20130158037 Compounds and methods for treating tuberculosis infection |
06/20/2013 | US20130158034 Trpm8 antagonists and their use in treatments |
06/20/2013 | US20130158032 Aminopyrimidine derivatives as lrrk2 modulators |
06/20/2013 | US20130158029 Sigma receptor inhibitors |
06/20/2013 | US20130158021 Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereof |
06/20/2013 | US20130158020 Indazole derivatives useful as erk inhibitors |
06/20/2013 | US20130158019 Pyrimidine compounds that inhibit anaplastic lymphoma kinase |
06/20/2013 | US20130158011 Novel compounds |
06/20/2013 | US20130158009 Piperidinyl-substituted lactams as gpr119 modulators |
06/20/2013 | US20130158006 Aminopyrimidine derivatives as lrrk2 modulators |
06/20/2013 | US20130158005 Pyrimidine derivatives as fak inhibitors |
06/20/2013 | US20130158004 Azetidine Derivatives |
06/20/2013 | US20130158003 Heteroaryl compounds and methods of use thereof |
06/20/2013 | US20130158001 Substituted 3-phenyl-1,2,4-oxadiazole compounds |
06/20/2013 | US20130157997 Benzimidazole analogues for the treatment or prevention of flavivirus infections |
06/20/2013 | US20130157996 Trpm8 antagonists and their use in treatments |
06/20/2013 | CA2858025A1 Chemical compound useful as intermediate for preparing a catechol-o-methyltransferase inhibitor |
06/20/2013 | CA2857197A1 Novel glp-1 receptor modulators |
06/19/2013 | EP2604606A1 Inhibitor of casein kinase 1 and casein kinase 1 |
06/19/2013 | EP2604602A1 Heteroaryl-pyrazole derivative |
06/19/2013 | EP2604597A1 Heterocyclic compound and use thereof |
06/19/2013 | EP2604595A1 Triazine derivative and pharmaceutical compound that contains same and exhibits analgesic activity |
06/19/2013 | EP2603506A1 Process for making linezolid |
06/19/2013 | EP2603505A1 Process for making linezolid |
06/19/2013 | EP2603504A1 Hepatitis c virus inhibitors |
06/19/2013 | EP2603502A1 4 - aminoquinazolin- 2 - yl - 1 - pyrrazole - 4 - carboxylic acid compounds as prolyl hydroxylase inhibitors |
06/19/2013 | EP2603500A1 Inhibitors of bruton's tyrosine kinase |
06/19/2013 | EP2603496A1 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds |
06/19/2013 | EP2603216A1 Heteroaryls and uses thereof |
06/19/2013 | EP2603079A1 Positive allosteric modulators of mglur2 |
06/19/2013 | CN103168037A Synthesis and use of kinase inhibitors |
06/19/2013 | CN103159751A A preparation method for the derivates of phenylpyruvic acid amide ketals |
06/19/2013 | CN103159742A 5-Chloropyrimidine compound and application of 5-Chloropyrimidine compound serving as epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor |
06/19/2013 | CN103159693A Chiral aryl-substituted phenyl-1,3-oxazoline compound and synthesis method thereof |
06/19/2013 | CN102276585B Preparation method for and medicinal usage of 4-substituted-phenyl-aryl-carboxylate derivatives |
06/19/2013 | CN101910159B Process for production of heterocycle-substituted pyridine derivative |
06/19/2013 | CN101880276B Substituted diazepan compounds as orexin receptor antagonists |
06/19/2013 | CN101809099B Organic fluorescent sulfonyl ureido benzoxazinone pigments |
06/19/2013 | CN101754966B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
06/19/2013 | CN101678214B 芳基醚哒嗪酮衍生物 Aryl ether pyridazinones |
06/18/2013 | US8466282 Heterocyclic compound and use thereof |
06/18/2013 | US8466165 4-phenylamino-quinazolin-6-yl-amides |
06/18/2013 | US8466149 6-substituted sulfonyl azabicyclo[3.2.1]octanes useful to inhibit 11β-hydroxysteroid dehydrogenase type-I |
06/18/2013 | US8466148 1,2-disubstituted heterocyclic compounds |
06/18/2013 | US8466146 Cyclothiocarbamate derivatives as progesterone receptor modulators |
06/18/2013 | US8466145 Dipeptidyl peptidase IV inhibitors |
06/18/2013 | CA2567506C Cyclic amide derivatives, and their production and use as antithrombotic agents |
06/13/2013 | WO2013086229A1 Bicyclic aryl and heteroaryl sodium channel inhibitors |
06/13/2013 | WO2013085957A1 Substituted piperidinyl-pyridazinyl derivatives useful as scd 1 inhibitors |
06/13/2013 | WO2013085954A1 Substituted piperidinyl-carboxamide derivatives useful as scd 1 inhibitors |
06/13/2013 | WO2013085018A1 Phenylpyrrole derivative |
06/13/2013 | WO2013084013A1 Cycloalkane carboxylic acid derivatives as cxcr3 receptor antagonists |
06/13/2013 | WO2013083991A1 Novel compounds and their use in therapy |
06/13/2013 | WO2013083859A2 Substituted n-(tetrazol-5-yl)- and n-(triazol-5-yl)arylcarboxamide compounds and their use as herbicides |
06/13/2013 | WO2013083774A1 Herbicidal compounds |
06/13/2013 | WO2013083591A1 Substituted pyrazoles as mglu5 receptor modulators |
06/13/2013 | WO2013083557A1 6-difluoromethyl-5,6-dihydro-2h-[1,4]oxazin-3-amine derivatives |
06/13/2013 | WO2013083556A1 5-(3-aminophenyl)-5-alkyl-5,6-dihydro-2h-[1,4]oxazin-3-amine derivatives |
06/13/2013 | WO2013048169A3 Method for preparing taxane derivatives |
06/13/2013 | WO2013043232A3 8-ethyl-6-(aryl)pyrido [2,3-d]pyrimidin-7(8h) -ones for the treatment of nervous system disorders and cancer |
06/13/2013 | WO2012177893A3 Trpm8 antagonists and their use in treatments |
06/13/2013 | US20130150574 Process for the manufacture of chiral catalysts and their salts |
06/13/2013 | US20130150417 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response |
06/13/2013 | US20130150411 Novel pyridine derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
06/13/2013 | US20130150377 Tetrahydropyridinyl and Dihydropyrrolyl Compounds and the Use Thereof |
06/13/2013 | US20130150369 Benzotriazine Oxides as Drugs Targeting Mycobacterium Tuberculosis |
06/13/2013 | US20130150365 Insecticidal Triazines and Pyrimidines |
06/13/2013 | US20130150360 Inhibitors of bruton's tyrosine kinase |
06/13/2013 | US20130150356 Acyl Piperazine Derivatives as TTX-S Blockers |
06/13/2013 | US20130150355 Novel compounds |
06/13/2013 | US20130150349 2,4-pyrimidinediamine compounds and their uses |
06/13/2013 | US20130150344 Heterocyclic compound |
06/13/2013 | US20130150341 Novel compounds |
06/13/2013 | US20130150325 3-(Fluorovinyl)pyrazoles and their use |
06/13/2013 | CA2858342A1 Phenylpyrrole derivative |
06/13/2013 | CA2857198A1 Cycloalkane carboxylic acid derivatives as cxcr3 receptor antagonists |
06/13/2013 | CA2855351A1 Novel pyrrole derivatives |
06/13/2013 | CA2854608A1 Herbicidal compounds |
06/13/2013 | CA2853891A1 5-(3-aminophenyl)-5-alkyl-5,6-dihydro-2h-[1,4]oxazin-3-amine derivatives |
06/13/2013 | CA2852366A1 6-difluoromethyl-5,6-dihydro-2h-[1,4]oxazin-3-amine derivatives |
06/12/2013 | EP2602248A1 Novel pyrrole compounds |
06/12/2013 | EP2601950A1 Cycloalkane carboxylic acid derivatives as CXCR3 receptor antagonists |
06/12/2013 | EP2601190A1 Isoxazoline derivatives as antiparasitic agents |
06/12/2013 | EP2601189A1 N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides as inhibitors of plasma kallikrein |
06/12/2013 | EP2600874A1 Pyrimidine compounds that inhibit anaplastic lymphoma kinase |
06/12/2013 | EP2475657B1 5-alkinylthien-2-ylcarboxylic acids as inhibitors of flaviviridae viruses |
06/12/2013 | EP2178869B1 Indole compounds as an inhibitor of cellular necrosis |
06/12/2013 | CN1854135B Heteronuclear compound with dicyandiamide connection and its medicinal use |
06/12/2013 | CN103155268A Photoelectric conversion element, pigment for photoelectric conversion element and compound |
06/12/2013 | CN103153990A Novel pyridyl benzoxazine derivatives, pharmaceutical composition comprising the same, and use thereof |
06/12/2013 | CN103153978A Compounds and methods for the treatment or prevention of flaviviridae viral infections |
06/12/2013 | CN103153970A Oxazole And Thiazole Compounds As Ksp Inhibitors |
06/12/2013 | CN103153968A Triazine derivative and pharmaceutical compound that contains same and exhibits analgesic activity |
06/12/2013 | CN103153963A Cyclopropane compound |
06/12/2013 | CN103153957A N-pyridin-3-yl or N-pyrazin-2-yl carboxamides |
06/12/2013 | CN103153951A Pyrrolidinones as MetAP-2 inhibitors |
06/12/2013 | CN103145702A Aminopyrimidines useful as kinase inhibitors |